A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
Authors:
- Valerie J. LewingtonVLValerie J. Lewington
- Duncan M. AckeryDADuncan M. Ackery
- Maureen A. ZivanovicMZMaureen A. Zivanovic
- 1 August 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (8) , 954-958
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Strontium-89 chloride for pain palliation in prostatic skeletal malignancyBritish Journal of Radiology, 1991
- Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- Sr-89 therapy for metastatic bone disease: scintigraphic and radiographic follow-up.Radiology, 1987
- Bone Metastasis Prognosis, Diagnosis and TreatmentActa Radiologica: Oncology, 1986
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones aloneCancer, 1983
- The Impact of Current Staging Procedures in Assessing Disease Extent of Prostatic AdenocarcinomaJournal of Urology, 1979
- Results of 89 Strontium Therapy in Patients with Carcinoma of the Prostate and Incurable Pain from Bone Metastases: A Preliminary ReportJournal of Urology, 1976